Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C14H16BrCl2NO2S and a molecular weight of approximately 413.15 g/mol. It is classified as an experimental drug and does not have an established therapeutic use or detailed pharmacological profile in public databases. The structure features a cyclopropanecarboxamide core substituted with dichloro, methanesulfinyl, methyl groups and an amide linkage to a 4-bromophenylethyl moiety. No mechanism of action or clinical indication has been reported for this compound in available sources[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2,2-dichloro-1-methanesulfinyl-3-methyl-cyclopropanecarboxylic acid [1-(4-bromo-phenyl)-ethyl]-amide.